Literature DB >> 10381913

Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach.

C S Chang1, L T Chen, J C Yang, J T Lin, K C Chang, J T Wang.   

Abstract

BACKGROUND & AIMS: The growth of gastric mucosa-associated lymphoid tissue lymphoma (MALToma) seems to depend on the stimulation of Helicobacter pylori. We attempted to identify specific antigen(s) from H. pylori strains associated with MALToma.
METHODS: Membranous and secreted proteins of H. pylori were compared on sodium dodecyl sulfate-polyacrylamide gel electrophoresis by Western blot using sera from patients with MALToma.
RESULTS: A 19-kilodalton protein was seen in all strains isolated from patients with MALToma but uncommonly in other strains. The protein was purified and sequenced. Amino acid sequence comparison showed it was an FldA homologue, a putative flavodoxin protein. DNA sequencing in 26 strains revealed that a nucleotide G insertion at position 481 of the fldA gene was more frequently observed in strains associated with MALToma than other strains (9/9 vs. 6/17; P = 0.002). The mutation caused a short truncation. A recombinant protein with this truncation was expressed and tested. Sera of 12 (70.6%) of 17 patients with MALToma were positive for the antibody to the recombinant protein, and 7 (16.7%) of 42 control patients were positive (12/17 vs. 7/42; P < 0.0001).
CONCLUSIONS: Truncated FldA of H. pylori is associated with gastric MALToma. It may be involved in the pathogenesis of gastric MALToma. Antibody to this antigen could be used as a serological marker of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381913     DOI: 10.1016/s0016-5085(99)70553-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Sequence analysis and clinical significance of the iceA gene from Helicobacter pylori strains in Japan.

Authors:  Y Ito; T Azuma; S Ito; H Suto; H Miyaji; Y Yamazaki; T Kato; Y Kohli; Y Keida; M Kuriyama
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.

Authors:  Dirk Bumann; Sevil Aksu; Meike Wendland; Katharina Janek; Uschi Zimny-Arndt; Nicolas Sabarth; Thomas F Meyer; Peter R Jungblut
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis.

Authors:  H Enroth; T Akerlund; A Sillén; L Engstrand
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

4.  Evaluation of the role of H pylori infection in pathogenesis of gastric cancer by immunoblot assay.

Authors:  Kuo-Ching Yang; Alexander Chu; Chao-Sheng Liao; Yu-Min Lin; Gen-Min Wang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

5.  Crystal structure of oxidized flavodoxin, an essential protein in Helicobacter pylori.

Authors:  Jörg Freigang; Kay Diederichs; Klaus P Schäfer; Wolfram Welte; Ralf Paul
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

Review 6.  A critical review of the effect of Helicobacter pylori eradication on gastric MALT lymphoma.

Authors:  A C Wotherspoon
Journal:  Curr Gastroenterol Rep       Date:  2000-12

Review 7.  Helicobacter pylori-Associated Diseases.

Authors:  Michael K Sanders; David A Peura
Journal:  Curr Gastroenterol Rep       Date:  2002-12

8.  Genome sequence of Helicobacter suis supports its role in gastric pathology.

Authors:  Miet Vermoote; Tom Theo Marie Vandekerckhove; Bram Flahou; Frank Pasmans; Annemieke Smet; Dominic De Groote; Wim Van Criekinge; Richard Ducatelle; Freddy Haesebrouck
Journal:  Vet Res       Date:  2011-03-17       Impact factor: 3.683

Review 9.  Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens.

Authors:  Sandra Salillas; Javier Sancho
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.